Published in Biochim Biophys Acta on August 23, 1977
Fibronectins: multifunctional modular glycoproteins. J Cell Biol (1982) 8.05
Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol (1981) 5.60
Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med (1981) 3.93
Partial primary structure of bovine plasma fibronectin: three types of internal homology. Proc Natl Acad Sci U S A (1983) 3.16
Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma. J Clin Invest (1977) 2.96
Isolation and characterization of cDNA clones for human and bovine fibronectins. Proc Natl Acad Sci U S A (1983) 2.10
Affinity modulation of integrin alpha 5 beta 1: regulation of the functional response by soluble fibronectin. J Cell Biol (1993) 1.86
Deposition of plasma fibronectin in tissues. Proc Natl Acad Sci U S A (1981) 1.68
Functional domain structure of fibronectin. Proc Natl Acad Sci U S A (1980) 1.59
Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: two mechanisms with divergent biological consequences. J Exp Med (1994) 1.39
Identification and isolation of a collagen-binding fragment of the adhesive glycoprotein fibronectin. Proc Natl Acad Sci U S A (1979) 1.32
Augmentation of human monocyte opsonin-independent phagocytosis by fragments of human plasma fibronectin. Proc Natl Acad Sci U S A (1981) 1.32
Vascular endothelial cells maintained in the absence of fibroblast growth factor undergo structural and functional alterations that are incompatible with their in vivo differentiated properties. J Cell Biol (1979) 1.16
Immunochemical characterization of human plasma fibronectin. Biochem J (1980) 1.06
Isolation of an actin-binding fragment of fibronectin. Biochem J (1981) 0.95
Fibronectin fragmentation is a feature of periodontal disease sites and diabetic foot and leg wounds and modifies cell behavior. J Periodontol (2008) 0.93
Association of fibronectin with carboxy-group-modified proteins in vitro. Biochem J (1982) 0.88
Solution and surface effects on plasma fibronectin structure. J Cell Biol (1983) 0.87
Fibronectin from chicken embryo fibroblasts contains covalently bound phosphate. J Cell Biol (1979) 0.83
Reversible binding of a guinea-pig lymphokine to gelatin and fibrinogen: possible relationship of macrophage agglutination factor and fibronectin. Immunology (1982) 0.81
Polypeptide heterogeneity of hamster and calf fibronectins. Biochem J (1980) 0.81
The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. J Biol Chem (1970) 4.49
Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med (1981) 3.93
Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma. J Clin Invest (1977) 2.96
The structure and biologic activities of plasma fibronectin. Blood (1980) 2.94
The cold-insoluble globulin of human plasma: studies of its essential structural features. Biochim Biophys Acta (1975) 2.51
Identification and mass analysis of human fibrinogen molecules and their domains by scanning transmission electron microscopy. J Mol Biol (1981) 2.01
Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol (2001) 1.76
Gigantic jets between a thundercloud and the ionosphere. Nature (2003) 1.70
Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B Biomed Sci Appl (2001) 1.57
Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes. J Clin Invest (1973) 1.54
Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb Haemost (2001) 1.48
Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease. Arthritis Rheum (1981) 1.38
Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates. J Biol Chem (1972) 1.37
Production of fibronectin by human epithelial cells in culture. Cancer Res (1979) 1.34
The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry (1966) 1.31
Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents. J Clin Invest (1987) 1.26
Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration. J Clin Invest (1979) 1.22
Control of a cell surface major glycoprotein by epidermal growth factor. Science (1977) 1.21
Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Exp Cell Res (1997) 1.19
Human fibrinogen of relatively high solubility. Comparative biophysical, biochemical, and biological studies with fibrinogen of lower solubility. Biochemistry (1967) 1.17
Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry (1996) 1.16
An improved method for purification of the cold-insoluble globulin of human plasma (CLg). Anal Biochem (1977) 1.16
Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). Blood (1987) 1.16
Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts. Association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells. Lab Invest (1979) 1.15
Identification and characterization of the thrombin binding sites on fibrin. J Biol Chem (1996) 1.13
Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. Proc Natl Acad Sci U S A (1989) 1.10
Cryoprecipitation of fibrin-fibrinogen complexes induced by the cold-insoluble globulin of plasma. Blood (1978) 1.10
Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma'). Proc Natl Acad Sci U S A (1980) 1.08
Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans. Transplantation (1990) 1.07
Chronic intravascular coagulation syndrome. N Engl J Med (1968) 1.06
Human platelet fibrinogen: purification and hemostatic properties. Blood (1985) 1.05
Human fibrinogen heterogeneities. 3. Identification of chain variants. J Biol Chem (1972) 1.04
Comparison of human plasma fibrinogen subfractions and early plasmic fibrinogen derivatives. J Biol Chem (1974) 1.01
ELISA for quantitation of tumor necrosis factor-alpha in serum. J Pharm Biomed Anal (1987) 1.01
The cold-insoluble globulin of plasma and its relationship to factor VIII. J Lab Clin Med (1974) 1.00
The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis. J Biol Chem (1973) 0.99
Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen). J Biol Chem (2000) 0.99
Characterization of the gamma chain platelet binding site on fibrinogen fragment D. Blood (1992) 0.99
Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thromb Haemost (2002) 0.99
Human fibrinogen heterogeneities: distribution and charge characteristics of chains of A alpha origin. J Lab Clin Med (1978) 0.97
Purification and characterization of proteins excreted by cells infected with herpes simplex virus and their use in diagnosis. Virology (1978) 0.96
Effect of hepatocyte-stimulating factor and glucocorticoids on plasma fibronectin levels. Biochem J (1986) 0.96
Identification of the cold-insoluble globulin of plasma in amniotic fluid. Am J Obstet Gynecol (1976) 0.96
Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis. J Biol Chem (1994) 0.96
Studies of fibronectin synthesized by cultured chick hepatocytes. Exp Cell Res (1985) 0.95
Cleavage of fibrinogen by human platelet calcium-activated protease. Thromb Res (1984) 0.95
Evidence that binding to the carboxyl-terminal heparin-binding domain (Hep II) dominates the interaction between plasma fibronectin and heparin. Biochemistry (1988) 0.94
Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'). Biochemistry (1981) 0.94
Application of electroimmunoassay to the study of plasma protein synthesis in cultured hepatocytes. Ann Clin Lab Sci (1980) 0.93
Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia. J Clin Invest (1993) 0.93
Hormonal regulation of fibrinogen synthesis in cultured hepatocytes. Ann N Y Acad Sci (1983) 0.92
Difficulties in precise quantitation of CD4+ T lymphocytes for clinical trials: a review. Biologicals (1993) 0.92
The amino acid sequence in fibrin responsible for high affinity thrombin binding. Thromb Haemost (2001) 0.89
Cold-insoluble globulin (CIg), a circulating cell surface protein. Thromb Haemost (1977) 0.88
Human fibrinogen heterogeneities. II. Cross-linking capacity of high solubility catabolic intermediates. J Biol Chem (1972) 0.88
Human plasma fibronectin structure probed by steady-state fluorescence polarization: evidence for a rigid oblate structure. Biochemistry (1990) 0.88
A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibody. J Immunol Methods (1997) 0.88
Low incidence of antibodies to recombinant human tissue-type plasminogen activator in treated patients. Thromb Haemost (1990) 0.88
Separation and analysis of the major forms of plasma fibronectin. Biochim Biophys Acta (1983) 0.87
Thyroid hormone stimulation of plasma protein synthesis in cultured hepatocytes. J Biol Chem (1981) 0.87
Solution and surface effects on plasma fibronectin structure. J Cell Biol (1983) 0.87
Chromatographic, ultracentrifugal, and related studies of fibrinogen "Baltimore". J Clin Invest (1969) 0.87
Isolation and characterization of the clottable low molecular weight fibrinogen derived by limited plasmin hydrolysis of human fraction I-4. Biochemistry (1969) 0.86
Fibronectin deposition in delayed-type hypersensitivity. Reactions of normals and a patient with afibrinogenemia. J Clin Invest (1984) 0.86
Studies of platelet fibrinogen from a subject with a congenital plasma fibrinogen abnormality (fibrinogen Paris I). Blood (1979) 0.86
Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair. J Invest Dermatol (2001) 0.86
[Hemorrhagic diathesis with dominant heredity, caused by an abnormal fibrinogen (fibrinogen Baltimore)]. Schweiz Med Wochenschr (1966) 0.85
The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin. J Biol Chem (1990) 0.85
D-Phe-Pro-Arg-chloromethylketone: its potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy. Thromb Haemost (1986) 0.84
Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules. Blood (1988) 0.84
Primary structure of the amino terminal regions of chicken fibrin chains. Thromb Res (1977) 0.84
Preparation of functionally intact monomers by limited disulfide reduction of human plasma fibronectin dimers. Arch Biochem Biophys (1985) 0.83
Analysis of human fibrinogen by scanning transmission electron microscopy. Ann N Y Acad Sci (1983) 0.83
Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa. Thromb Haemost (1995) 0.83
Cyclic AMP response to recombinant human relaxin by cultured human endometrial cells--a specific and high throughput in vitro bioassay. Biochem Biophys Res Commun (1990) 0.82
Studies on the structure of bovine factor V by scanning transmission electron microscopy. Blood (1985) 0.82
Factors affecting gamma-chain multimer formation in cross-linked fibrin. Biochemistry (1992) 0.82
Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain. Thromb Haemost (1993) 0.82
Steroid effects on fibrinogen synthesis by cultured embryonic chicken hepatocytes. Biochem Med (1975) 0.82
Human platelet fibrinogen gamma chain structure. Blood (1984) 0.82
Near ultraviolet circular dichroism spectroscopy of plasma fibronectin and fibronectin fragments. Biochem Biophys Res Commun (1982) 0.81